What has changed
The federal government has amended the rules governing the Growth Hormone Program, a scheme under the National Health Act 1953 administered by the Department of Health, Disability and Ageing. The amending instrument is the National Health (Growth Hormone Program) Special Arrangement Amendment (Somapacitan) Instrument 2026.
The amendment adds somapacitan as a product covered under the program's special arrangement.
Dates
- The instrument commenced on 24 June 2026.
- The instrument is in force until 14 September 2026.
What the source does not say
The source does not specify what happens after 14 September 2026, or what the amendment changes in practical terms beyond adding somapacitan to the schedule.
Where to find the full instrument
The full text of the instrument is available on the Federal Register of Legislation at https://www.legislation.gov.au/F2026L00771. The Federal Register of Legislation is the place to monitor for any further amendments or replacement instruments after 14 September 2026.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.